Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsfetal-neonatal-and-perinatal

Paeds SAQs · fetal-neonatal-and-perinatal

Neonatal anaemia, polycythaemia and thrombocytopenia: SAQ

Short-answer questions covering a term neonate with severe thrombocytopenia from neonatal alloimmune thrombocytopenia and a preterm infant with the anaemia of prematurity.

20 marks30 min3 min readSource-verified ·

Target exams

RACP DWEMRCPCH TheoryABP General Pediatrics
On this page
Study tools

Target exams

RACP DWEMRCPCH TheoryABP General Pediatrics
Prompt
A term male infant weighing 3.4 kg is born by normal vaginal delivery at 39 weeks to a 28-year-old mother with a normal platelet count of 240 times 10 to the 9 per litre. At 6 hours of life, widespread petechiae are noted over the face and trunk. The infant is otherwise alert and feeding well. A full blood count shows haemoglobin 165 g per litre, white cell count 12 times 10 to the 9 per litre, and platelet count 14 times 10 to the 9 per litre. The maternal platelet count is normal. There is a history of a previous child who had severe neonatal thrombocytopenia requiring platelet transfusion.

Part A (10 marks)

a) What is the most likely diagnosis, and what is the underlying pathophysiology? (3 marks) [2]

The most likely diagnosis is fetal and neonatal alloimmune thrombocytopenia: isolated severe thrombocytopenia at birth in an otherwise well term infant, a normal maternal platelet count, and a previously affected sibling. Maternal immunoglobulin G against a paternally inherited human platelet antigen (most often HPA-1a in European ancestry) crosses the placenta and destroys fetal platelets. Clinically apparent immunisation usually occurs in the first pregnancy. [3]

b) What immediate investigation is required, and why? (2 marks) [3]

Cranial imaging for intracranial haemorrhage is required urgently in every newborn with suspected fetal and neonatal alloimmune thrombocytopenia, regardless of the current platelet count. Haemorrhage may be clinically silent. [3]

c) Outline the immediate management, including the blood product of choice. (3 marks) [2]

Transfuse platelets without delay. HPA-selected (typically HPA-1a-negative) units are preferred if immediately available. If they are not, unselected platelets should be transfused; a matched-donor search must not postpone the first transfusion. Optimal volume (10 versus 20 mL per kg) is unknown. Postnatal intravenous immunoglobulin alone, or added to platelets, does not provide additional therapeutic benefit. For life-threatening bleeding, target at least 100 times 10 to the 9 per litre initially. [3]

d) What should parents be told about subsequent pregnancies, and what antenatal intervention is offered? (2 marks) [2]

Severe thrombocytopenia is expected in the majority of subsequent pregnancies if the fetus inherits the antigen. After a previous intracranial haemorrhage, one series reported recurrence in 11 of 13 cases. Offer antenatal intravenous immunoglobulin in subsequent affected pregnancies: as early as 12 weeks after previous haemorrhage (Lieberman), commonly 1 g per kg per week from 20 to 24 weeks (Sachs). [3]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References7ShowHide
  1. [1]Stanworth SJ How I diagnose and treat neonatal thrombocytopenia. Blood, 2023.PMID 36787503
  2. [2]Lieberman L Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach. Br J Haematol, 2019.PMID 30828796
  3. [3]Sachs UJ Diagnosis and Management of Fetal and Neonatal Alloimmune Thrombocytopenia: An Update 2025. Transfus Med Hemother, 2025.PMID 41089465
  4. [4]Kirpalani H Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants. N Engl J Med, 2020.PMID 33382931
  5. [5]Gisslen T Anemia, Iron Supplementation, and the Brain. Clin Perinatol, 2023.PMID 37866852
  6. [6]Widness JA Pathophysiology of Anemia During the Neonatal Period, Including Anemia of Prematurity. NeoReviews, 2008.PMID 20463861
  7. [7]Manapurath RM Enteral Iron Supplementation in Preterm or Low Birth Weight Infants: A Systematic Review and Meta-analysis. Pediatrics, 2022.PMID 35921671
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousNeonatal air-leak syndromes — formative SAQsfetal-neonatal-and-perinatalNextNeonatal bacterial infection and sepsis: SAQfetal-neonatal-and-perinatal